Article

Using Telehealth technology to deliver pulmonary rehabilitation in chronic obstructive pulmonary disease patients.

Department of Medicine, University of Alberta, Edmonton, Alberta, Canada.
Canadian respiratory journal: journal of the Canadian Thoracic Society (Impact Factor: 1.29). 07/2011; 18(4):216-20.
Source: PubMed

ABSTRACT Pulmonary rehabilitation (PR) is an effective therapeutic strategy to improve health outcomes in patients with chronic obstructive pulmonary disease (COPD); however, there is insufficient PR capacity to service all COPD patients, thus necessitating creative solutions to increase the availability of PR.
To examine the efficacy of PR delivered via Telehealth (Telehealth-PR) compared with PR delivered in person through a standard outpatient hospital-based program (Standard-PR).
One hundred forty-seven COPD patients participated in an eight-week rural PR program delivered via Telehealth-PR. Data were compared with a parallel group of 262 COPD patients who attended Standard-PR. Education sessions were administered two days per week via Telehealth, and patients exercised at their satellite centre under direct supervision. Standard-PR patients viewed the same education sessions in person and exercised at the main PR site. The primary outcome measure was change in quality of life as evaluated by the St George's Respiratory Questionnaire (SGRQ). A noninferiority analysis was performed using both intention-to-treat and per-protocol approaches.
Both Telehealth-PR and Standard-PR resulted in clinically and statistically significant improvements in SGRQ scores (4.5 ± 0.8% versus 4.1 ± 0.6%; P<0.05 versus baseline for both groups), and the improvement in SGRQ was not different between the two programs. Similarly, exercise capacity, as assessed by 12 min walk test, improved equally in both Telehealth-PR and Standard-PR programs (81±10 m versus 82 ± 10 m; P<0.05 versus baseline for both groups).
Telehealth-PR was an effective tool for increasing COPD PR services, and demonstrated improvements in quality of life and exercise capacity comparable with Standard-PR.

0 Bookmarks
 · 
89 Views
  • [Show abstract] [Hide abstract]
    ABSTRACT: Respiratory therapy (RT) has been shown to improve dyspnea, exercise capacity and health-related quality of life in patients with COPD. RT has also shown benefits in diseases other than COPD but the degree of evidence is lower. The fundamental components of RT programs are muscle training, education and chest physiotherapy. Occupational therapy, psychosocial support and nutritional intervention should also be considered. Home programs have been shown to be as effective as hospital therapy. The duration of rehabilitation programs should not be less than 8 weeks or 20 sessions. Early initiation of RT, even during exacerbations, has proven safe and effective. The use of oxygen or noninvasive ventilation during training is controversial and dependent on the patient's situation. At present, the best strategy for maintaining the benefits of RT in the long term is unknown. Longer RT programs or telemedicine could play a key role in extending the results obtained.
    Archivos de bronconeumologia. 05/2014;
  • [Show abstract] [Hide abstract]
    ABSTRACT: Variable aspects of pulmonary rehabilitation (PR) programs include staff composition, setting, structure, and duration. Longer PR programs generally translate into greater improvements in outcomes and (perhaps) prolonged maintenance of benefits. Barriers to PR include transportation issues, inconvenience for the patient, cost and insurance coverage problems, lack of perceived benefit, concurrent illness, and influence of the provider. PR settings include inpatient and outpatient environments. PR has been shown to improve health care utilization during or immediately following chronic obstructive pulmonary disease exacerbations. Challenges to providing PR may be partially addressed by technological developments.
    Clinics in Chest Medicine. 01/2014;
  • [Show abstract] [Hide abstract]
    ABSTRACT: Abstract The telemedicine intervention in chronic disease management promises to involve patients in their own care, provides continuous monitoring by their healthcare providers, identifies early symptoms, and responds promptly to exacerbations in their illnesses. This review set out to establish the evidence from the available literature on the impact of telemedicine for the management of three chronic diseases: congestive heart failure, stroke, and chronic obstructive pulmonary disease. By design, the review focuses on a limited set of representative chronic diseases because of their current and increasing importance relative to their prevalence, associated morbidity, mortality, and cost. Furthermore, these three diseases are amenable to timely interventions and secondary prevention through telemonitoring. The preponderance of evidence from studies using rigorous research methods points to beneficial results from telemonitoring in its various manifestations, albeit with a few exceptions. Generally, the benefits include reductions in use of service: hospital admissions/re-admissions, length of hospital stay, and emergency department visits typically declined. It is important that there often were reductions in mortality. Few studies reported neutral or mixed findings.
    Telemedicine journal and e-health : the official journal of the American Telemedicine Association. 06/2014;

Full-text (2 Sources)

Download
10 Downloads
Available from
May 29, 2014